Spine

Banner Health / Atlas Healthcare Partners Joint Venture Partner with Advanced Spine and Pain, LLC to Announce 21st Ambulatory Surgery Center Serving Central-Phoenix Area

Retrieved on: 
Tuesday, October 26, 2021

PHOENIX, Oct. 26, 2021 /PRNewswire/ -- Atlas Healthcare Partners , which specializes in developing and managing ambulatory surgery centers (ASCs) in partnership with health systems and physicians,today announced its 21st Banner Surgery Center with the partnership of Advanced Spine and Pain, LLC and Sonospine.

Key Points: 
  • PHOENIX, Oct. 26, 2021 /PRNewswire/ -- Atlas Healthcare Partners , which specializes in developing and managing ambulatory surgery centers (ASCs) in partnership with health systems and physicians,today announced its 21st Banner Surgery Center with the partnership of Advanced Spine and Pain, LLC and Sonospine.
  • The two will now be known and operate as Banner Surgery Center (BSC) Central Phoenix.
  • Atlas's partnership-first model works to deliver long-term success and profitability for the health systems and physicians they work with.
  • In 2018, Banner Health partnered with Atlas Healthcare Partners to develop, manage, and grow their ASC network.

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

Retrieved on: 
Tuesday, October 26, 2021

Dr. Saha has 7+ years of experience in the FDA and 10+ years of clinical research experience in medical robotics and prosthetics.

Key Points: 
  • Dr. Saha has 7+ years of experience in the FDA and 10+ years of clinical research experience in medical robotics and prosthetics.
  • Dr. Saha has extensive knowledge of US regulatory processes associated with neurology and physical medicine devices.
  • Dr. Saha specializes in the review of medical exoskeletons, brain computer interfaces, physical rehabilitation devices including wearable technology, and early feasibility studies.
  • About MCRA, LLC:MCRA is the leading privately held independent medical device, diagnostics, and biologics advisory firm and Clinical Research Organization (CRO).

Global Osteoarthritis Therapeutics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 26, 2021

It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan.

Key Points: 
  • It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan.
  • How has the global osteoarthritis therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
  • What is the structure of the global osteoarthritis therapeutics market and who are the key players?

Global Microscope Market Size, Share & Trends Analysis Report 2021-2028: Growing Demand in Application Areas - Miniature Transistor Chips and Quantum - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 26, 2021

The "Global Microscope Market Size, Share & Trends Analysis Report by Product (Optical, Electron, Scanning Probe), by Application (Nanotechnology, Life Science), by Region (North America, Europe, APAC, MEA), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Microscope Market Size, Share & Trends Analysis Report by Product (Optical, Electron, Scanning Probe), by Application (Nanotechnology, Life Science), by Region (North America, Europe, APAC, MEA), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global microscope market size is expected to reach USD 17.5 billion by 2028., expanding at a CAGR of 7.93% over the forecast period.
  • High demand from the healthcare sector and rapidly growing semiconductor industry are the key factors boosting the market growth.
  • he growing adoption and rising investments in the development of microscopes by precision manufacturing industries are expected to drive market growth.

Kuros Biosciences Reports Continued Increase in MagnetOs U.S. Sales

Retrieved on: 
Tuesday, October 26, 2021

MagnetOs is an implant intended to fill bony voids or gaps of the skeletal system, i.e., posterolateral spine.

Key Points: 
  • MagnetOs is an implant intended to fill bony voids or gaps of the skeletal system, i.e., posterolateral spine.
  • MagnetOs must be used with autograft as a bone graft extender in the posterolateral spine.
  • MagnetOs should not be used to treat large defects that in the surgeons opinion would fail to heal spontaneously.
  • Kuros Biosciences is a fast-growing leader in the development of spinal fusion biologics that ease the burden of back pain.

Stryker Culminates Minor League Baseball Activation With $55,474 Donation To K9s For Warriors

Retrieved on: 
Monday, October 25, 2021

"There's no better way to celebrate the completion of our 10-city tour with Minor League Baseball than giving back to K9s For Warriors," said Don Payerle, president of Stryker's Joint Replacement division.

Key Points: 
  • "There's no better way to celebrate the completion of our 10-city tour with Minor League Baseball than giving back to K9s For Warriors," said Don Payerle, president of Stryker's Joint Replacement division.
  • "Stryker is dedicated to supporting our nation's military and through our relationship with K9s For Warriors, we're able to help empower veterans by sponsoring service canines."
  • Throughout the summer, Stryker joined Minor League Baseball fans nationwide to educate attendees on joint health and treatment options, including Mako SmartRobotics technology for joint replacement surgery and other non-surgical options.
  • Fans flock to Minor League Baseball games to see baseball's future stars and experience the affordable family-friendly entertainment that has been a staple of Minor League Baseball since 1901.

NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results

Retrieved on: 
Monday, October 25, 2021

NuVasivewill hold a conference call onTuesday, November 9, 2021, at4:30 p.m. ET/1:30 p.m. PTto discuss the results of its financial performance for the third quarter of 2021.

Key Points: 
  • NuVasivewill hold a conference call onTuesday, November 9, 2021, at4:30 p.m. ET/1:30 p.m. PTto discuss the results of its financial performance for the third quarter of 2021.
  • A live webcast of the conference call and supplemental financial information of the Company's third quarter financial results will be available on the Investor Relations page of the Company's website at www.nuvasive.com .
  • After the live event, the webcast will remain available onNuVasive'swebsite for 30 days.
  • NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.

Kindred Healthcare and El Camino Health Announce Plans for Inpatient Rehabilitation Hospital

Retrieved on: 
Friday, October 22, 2021

Kindred Healthcare, LLC (Kindred) announced today that it has signed a definitive agreement with El Camino Health to create a joint venture to construct and operate a 52-bed inpatient rehabilitation hospital in Sunnyvale, California, a city in northwest Santa Clara County.

Key Points: 
  • Kindred Healthcare, LLC (Kindred) announced today that it has signed a definitive agreement with El Camino Health to create a joint venture to construct and operate a 52-bed inpatient rehabilitation hospital in Sunnyvale, California, a city in northwest Santa Clara County.
  • For 11 years, El Camino Health and Kindred have worked together in providing acute rehabilitation at El Camino Healths Los Gatos hospital campus to help patients recover and rejoin the community after traumatic illness or injury.
  • For more than a decade, the dedicated professionals of both El Camino and Kindred have provided outstanding rehabilitative care to El Camino Healths patients and thanks to their proven success in improving health outcomes, we are excited to expand our relationship with El Camino Health, said Russ Bailey, president, Kindred Rehabilitation Services.
  • Kindred Healthcare, LLC is the nations leading specialty hospital company delivering acute health services in its long-term acute care hospitals, inpatient rehabilitation hospitals, acute rehabilitation units, and behavioral health line of business, all specializing in treating the most medically complex patients.

MCRA Hires Melissa Paper, JD, MPA, CHC as Vice President of Healthcare Compliance

Retrieved on: 
Thursday, October 21, 2021

WASHINGTON, Oct. 21, 2021 /PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostics, and biologics advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Cybersecurity, and Quality Assurance, is pleased to announce Melissa Paper, JD, MPA, CHC has joined MCRA as Vice President of Healthcare Compliance.

Key Points: 
  • WASHINGTON, Oct. 21, 2021 /PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostics, and biologics advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Cybersecurity, and Quality Assurance, is pleased to announce Melissa Paper, JD, MPA, CHC has joined MCRA as Vice President of Healthcare Compliance.
  • Prior to joining MCRA, Ms. Paper lead compliance programs for a variety of healthcare organizations including hospitals, physician practices, surgical centers, and urgent care centers.
  • Ms. Paper has also led revenue cycle compliance, coding compliance and privacy compliance teams.
  • David Lown, MCRA's President said "MCRA started offering healthcare compliance advisory services to our clients in 2005, as we recognized an effective compliance program is a fundamental business requirement for any healthcare organization.

SeaSpine to Report Third Quarter 2021 Financial Results on October 28, 2021

Retrieved on: 
Wednesday, October 20, 2021

CARLSBAD, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Thursday, October 28, 2021.

Key Points: 
  • CARLSBAD, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Thursday, October 28, 2021.
  • Members of the Companys management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.
  • To listen to a live webcast, please visit the Investors section of the SeaSpine website at: www.seaspine.com.
  • SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.